Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial

<h4>Background</h4> <p>To investigate the effect of BC1036 on health-related quality of life (QOL) in subjects with persistent cough. The secondary objective was to investigate the effect of BC1036 on subjective cough severity.</p> <h4>Methods</h4> <p>This...

Bibliográfalaš dieđut
Váldodahkkit:	Morice, A, McGarvey, L, Pavord, I, Higgins, B, Chung, K, Birring, S
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	AME Publishing Company 2017

Geahča maid

Recommendations for the management of cough in adults.
Dahkki: Morice, A, et al.
Almmustuhtton: (2006)

Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial
Dahkki: Wang, K, et al.
Almmustuhtton: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
Dahkki: Wang, K, et al.
Almmustuhtton: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial.
Dahkki: Wang, K, et al.
Almmustuhtton: (2014)

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
Dahkki: Wang, K, et al.
Almmustuhtton: (2013)

Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial.
Dahkki: Yousaf, N, et al.
Almmustuhtton: (2010)

Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
Dahkki: David R. Muccino, et al.
Almmustuhtton: (2020-11-01)

Cough
Dahkki: Birring, S, et al.
Almmustuhtton: (2012)

Cough
Dahkki: Birring, S, et al.
Almmustuhtton: (2008)

From bench to bedside: The role of cough hypersensitivity in chronic cough
Dahkki: Matthew G. Drake, et al.
Almmustuhtton: (2023-08-01)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
Dahkki: Alyn H. Morice, et al.
Almmustuhtton: (2015-10-01)

A double-blind randomised placebo-controlled trial investigating the effects of lesogaberan on the objective cough frequency and capsaicin-evoked coughs in patients with refractory chronic cough
Dahkki: Huda Badri, et al.
Almmustuhtton: (2022-03-01)

Effects of bepotastine, a nonsedating H1-antihistamine, for the treatment of persistent cough and allergic rhinitis: a randomised, double-blind, placebo-controlled trial
Dahkki: Ji-Hyang Lee, et al.
Almmustuhtton: (2023-10-01)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
Dahkki: Maki Komiyama, et al.
Almmustuhtton: (2023-04-01)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
Dahkki: Majed Al-Jeraisy, et al.
Almmustuhtton: (2021-04-01)

Chronic cough and gastro-oesophageal reflux.
Dahkki: Birring, S, et al.
Almmustuhtton: (2004)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Dahkki: Pavord, I, et al.
Almmustuhtton: (2012)

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Dahkki: Wang, Y, et al.
Almmustuhtton: (2020)

Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
Dahkki: Fiona C Denison, et al.
Almmustuhtton: (2019-12-01)

Cough and asthma.
Dahkki: Berry, M, et al.
Almmustuhtton: (2003)

Idiopathic chronic cough and organ-specific autoimmune disease.
Dahkki: Birring, S, et al.
Almmustuhtton: (2006)

An automated system for 24-h monitoring of cough frequency: the leicester cough monitor.
Dahkki: Matos, S, et al.
Almmustuhtton: (2007)

Cough frequency, cough sensitivity and health status in patients with chronic cough.
Dahkki: Birring, S, et al.
Almmustuhtton: (2006)

Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
Dahkki: Sharp, A, et al.
Almmustuhtton: (2017)

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough
Dahkki: David Muccino, et al.
Almmustuhtton: (2020-08-01)

The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough.
Dahkki: Birring, S, et al.
Almmustuhtton: (2008)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
Dahkki: Thwaites, GE, et al.
Almmustuhtton: (2017)

Assessment of gender differences in health status with the Leicester Cough Questionnaire (LCQ).
Dahkki: Birring, S, et al.
Almmustuhtton: (2009)

A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response.
Dahkki: Morice, A, et al.
Almmustuhtton: (2014)

Decoding the impact of the placebo response in clinical trials for chronic cough
Dahkki: Mengru Zhang, et al.
Almmustuhtton: (2024-10-01)

Four-hour cough frequency monitoring in chronic cough.
Dahkki: Lee, K, et al.
Almmustuhtton: (2012)

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial
Dahkki: Matthias Hepprich, et al.
Almmustuhtton: (2022-11-01)

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial
Dahkki: Richard A Furie, et al.
Almmustuhtton: (2020-10-01)

The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute).
Dahkki: Yousaf, N, et al.
Almmustuhtton: (2011)

Cough frequency in health and disease.
Dahkki: Yousaf, N, et al.
Almmustuhtton: (2013)

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
Dahkki: Horne, A, et al.
Almmustuhtton: (2020)

Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial
Dahkki: Ardalan H Zolnourian, et al.
Almmustuhtton: (2020-03-01)

Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
Dahkki: Sigismond Lasocki, et al.
Almmustuhtton: (2021-09-01)

Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia
Dahkki: Dan Siskind, et al.
Almmustuhtton: (2024-09-01)

Dexmedetomidine after Cardiac Surgery for Prevention of Delirium (EXACTUM) trial protocol: a multicentre randomised, double-blind, placebo-controlled trial
Dahkki: Emmanuel Futier, et al.
Almmustuhtton: (2022-04-01)